[1] McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021; 42: 3599−3726. doi: 10.1093/eurheartj/ehab368 [2] Roth GA, Forouzanfar MH, Moran AE, et al. Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med 2015; 372: 1333−1341. doi: 10.1056/NEJMoa1406656 [3] de Boer RA, Nayor M, deFilippi CR, et al. Association of cardiovascular biomarkers with incident heart failure with preserved and reduced ejection fraction. JAMA Cardiol 2018; 3: 215−224. doi: 10.1001/jamacardio.2017.4987 [4] van Oort S, Beulens JWJ, van Ballegooijen AJ, et al. Modifiable lifestyle factors and heart failure: A Mendelian randomization study. Am Heart J 2020; 227: 64−73. doi: 10.1016/j.ahj.2020.06.007 [5] Daiber A, Di Lisa F, Oelze M, et al. Crosstalk of mitochondria with NADPH oxidase via reactive oxygen and nitrogen species signalling and its role for vascular function. Br J Pharmacol 2017; 174: 1670−1689. doi: 10.1111/bph.13403 [6] Cesari M, Penninx BW, Newman AB, et al. Inflammatory markers and onset of cardiovascular events: results from the health ABC study. Circulation 2003; 108: 2317−2322. doi: 10.1161/01.CIR.0000097109.90783.FC [7] Vasan RS, Sullivan LM, Roubenoff R, et al. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation 2003; 107: 1486−1491. doi: 10.1161/01.CIR.0000057810.48709.F6 [8]

Georgiopoulos G, Chrysohoou C, Vogiatzi G, et al. Vitamins in heart failure: friend or enemy? Curr Pharm Des 2017; 23: 3731-3742.

[9] Shah AK, Dhalla NS. Effectiveness of some vitamins in the prevention of cardiovascular disease: a narrative review. Front Physiol 2021; 12: 729255. doi: 10.3389/fphys.2021.729255 [10] van der Pol A, van Gilst WH, Voors AA, van der Meer P. Treating oxidative stress in heart failure: past, present and future. Eur J Heart Fail 2019; 21: 425−435. doi: 10.1002/ejhf.1320 [11] Ahmed M, Azizi-Namini P, Yan AT, Keith M. Thiamin deficiency and heart failure: the current knowledge and gaps in literature. Heart Fail Rev 2015; 20: 1−11. doi: 10.1007/s10741-014-9432-0 [12] Hyppönen E, Läärä E, Reunanen A, et al. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001; 358: 1500−3. doi: 10.1016/S0140-6736(01)06580-1 [13] Eshak ES, Arafa AE. Thiamine deficiency and cardiovascular disorders. Nutr Metab Cardiovasc Dis 2018; 28: 965−72. doi: 10.1016/j.numecd.2018.06.013 [14] Song EK, Kang SM. Vitamin C deficiency, high-sensitivity C-reactive protein, and cardiac event-free survival in patients with heart failure. J Cardiovasc Nurs 2018; 33: 6−12. doi: 10.1097/JCN.0000000000000389 [15] Balasubramaniam S, Christodoulou J. Disorders of riboflavin metabolism. J Inherit Metab Dis 2019; 42: 608−619. doi: 10.1002/jimd.12058 [16] Keith ME, Walsh NA, Darling PB, et al. B-vitamin deficiency in hospitalized patients with heart failure. J Am Diet Assoc 2009; 109: 1406−1410. doi: 10.1016/j.jada.2009.05.011 [17] Kheiri B, Abdalla A, Osman M, et al. Vitamin D deficiency and risk of cardiovascular diseases: a narrative review. Clin Hypertens 2018; 24: 9. doi: 10.1186/s40885-018-0094-4 [18] Barteková M, Adameová A, Görbe A, et al. Natural and synthetic antioxidants targeting cardiac oxidative stress and redox signaling in cardiometabolic diseases. Free Radic Biol Med 2021; 169: 446−477. doi: 10.1016/j.freeradbiomed.2021.03.045 [19] Gutierrez AD, de Serna DG, Robinson I, Schade DS. The response of gamma vitamin E to varying dosages of alpha vitamin E plus vitamin C. Metabolism 2009; 58: 469−478. doi: 10.1016/j.metabol.2008.11.003 [20] Khan MS, Khan F, Fonarow GC, et al. Dietary interventions and nutritional supplements for heart failure: a systematic appraisal and evidence map. Eur J Heart Fail 2021; 23: 1468−1476. doi: 10.1002/ejhf.2278 [21] Lonn E, Bosch J, Yusuf S, et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 2005; 293: 1338−1347. doi: 10.1001/jama.293.11.1338 [22] Robinson T, Martin RM, Yarmolinsky J. Mendelian randomisation analysis of circulating adipokines and C-reactive protein on breast cancer risk. Int J Cancer 2020; 147: 1597−1603. doi: 10.1002/ijc.32947 [23] Burgess S, Scott RA, Timpson NJ, et al. Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur J Epidemiol 2015; 30: 543−552. doi: 10.1007/s10654-015-0011-z [24] Mondul AM, Yu K, Wheeler W, et al. Genome-wide association study of circulating retinol levels. Hum Mol Genet 2011; 20: 4724−4731. doi: 10.1093/hmg/ddr387 [25] Grarup N, Sulem P, Sandholt CH, et al. Genetic architecture of vitamin B12 and folate levels uncovered applying deeply sequenced large datasets. PLoS Genet 2013; 9: e1003530. doi: 10.1371/journal.pgen.1003530 [26] Zheng JS, Luan J, Sofianopoulou E, et al. Plasma vitamin C and type 2 diabetes: genome-wide association study and mendelian randomization analysis in European populations. Diabtes Care 2021; 44: 98−106. doi: 10.2337/dc20-1328 [27] Jiang X, O'Reilly PF, Aschard H. Genome-wide association study in 79,366 European-ancestry individuals informs the genetic architecture of 25-hydroxyvitamin D levels. Nat Commun 2018; 9: 260. doi: 10.1038/s41467-017-02662-2 [28] Major JM, Yu K, Wheeler W, et al. Genome-wide association study identifies common variants associated with circulating vitamin E levels. Hum Mol Genet 2011; 20: 3876−3883. doi: 10.1093/hmg/ddr296 [29] Long T, Hicks M. Whole-genome sequencing identifies common-to-rare variants associated with human blood metabolites. Nat Genet 2017; 49: 568−578. doi: 10.1038/ng.3809 [30] Shin SY, Fauman EB, Petersen AK, et al. An atlas of genetic influences on human blood metabolites. Nat Genet 2014; 46: 543−550. doi: 10.1038/ng.2982 [31] Shah S, Henry A. Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure. Nat Commun 2020; 11: 163. doi: 10.1038/s41467-019-13690-5 [32] Willer CJ, Schmidt EM, Sengupta S, et al. Discovery and refinement of loci associated with lipid levels. Nat Genet 2013; 45: 1274−1283. doi: 10.1038/ng.2797 [33] Howson JMM, Zhao W. Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms. Nat Genet 2017; 49: 1113−1119. doi: 10.1038/ng.3874 [34]

Luo J, le Cessie S, van Heemst D, Noordam R. Diet-derived circulating antioxidants and risk of coronary heart disease: a mendelian randomization study. J Am Coll Cardiol 2021; 77: 45−54.

[35] Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 2013; 37: 658−665. doi: 10.1002/gepi.21758 [36] Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 2016; 40: 304−314. doi: 10.1002/gepi.21965 [37] Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 2015; 44: 512−525. doi: 10.1093/ije/dyv080 [38] Chen W, Cai X, Yan H, Pan Y. Causal effect of obstructive sleep apnea on atrial fibrillation: a mendelian randomization study. J Am Heart Assoc 2021; 10: e022560. doi: 10.1161/JAHA.121.022560 [39] Verbanck M, Chen CY. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 2018; 50: 693−698. doi: 10.1038/s41588-018-0099-7 [40] Ji X, Hong J, Qu Z, et al. HemoglobinA1c is a risk factor for changes of bone mineral density: a mendelian randomization study. Front Endocrinol (Lausanne) 2022; 13: 942878. doi: 10.3389/fendo.2022.942878 [41] Nazarzadeh M, Pinho-Gomes AC, Bidel Z, et al. Plasma lipids and risk of aortic valve stenosis: a Mendelian randomization study. Eur Heart J 2020; 41: 3913−3920. doi: 10.1093/eurheartj/ehaa070 [42]

Tang Z, Wang P, Dong C, et al. Oxidative stress signaling mediated pathogenesis of diabetic cardiomyopathy. Oxid Med Cell Longev 2022; 2022: 5913374.

[43] Ye C, Geng Z, Zhang LL, et al. Chronic infusion of ELABELA alleviates vascular remodeling in spontaneously hypertensive rats via anti-inflammatory, anti-oxidative and anti-proliferative effects. Acta Pharmacol Sin 2022; 43: 2573−2584. doi: 10.1038/s41401-022-00875-w [44] Demaison L. Oxidative Stress and Obesity- and Type 2 Diabetes-Induced Heart Failure. Antioxidants (Basel) 2020; 9: 653. doi: 10.3390/antiox9080653 [45] Jiang M, Xie X, Cao F, Wang Y. Mitochondrial metabolism in myocardial remodeling and mechanical unloading: implications for ischemic heart disease. Front Cardiovasc Med 2021; 8: 789267. doi: 10.3389/fcvm.2021.789267 [46] Semba RD, Yuniar Y, Gamble MV, et al. Assessment of vitamin A status of preschool children in Indonesia using plasma retinol-binding protein. J Trop Pediatr 2002; 48: 84−87. doi: 10.1093/tropej/48.2.84 [47] Tsutsui H, Kinugawa S, Matsushima S. Oxidative stress and heart failure. Am J Physiol Heart Circ Physiol 2011; 301: H2181−H2190. doi: 10.1152/ajpheart.00554.2011 [48] Gao W, Wang H, Zhang L, et al. Retinol-binding protein 4 induces cardiomyocyte hypertrophy by activating TLR4/MyD88 pathway. Endocrinology 2016; 157: 2282−2293. doi: 10.1210/en.2015-2022 [49] Eshak ES, Iso H, Yamagishi K, et al. Dietary intakes of fat soluble vitamins as predictors of mortality from heart failure in a large prospective cohort study. Nutrition 2018; 47: 50−55. doi: 10.1016/j.nut.2017.09.009 [50] Wu JR, Song EK, Moser DK, Lennie TA. Dietary vitamin C deficiency is associated with health-related quality of life and cardiac event-free survival in adults with heart failure. J Cardiovasc Nurs 2019; 34: 29−35. doi: 10.1097/JCN.0000000000000521 [51]

Piquereau J, Boitard SE, Ventura-Clapier R, Mericskay M. Metabolic therapy of heart failure: is there a future for B vitamins? Int J Mol Sci 2021; 23.

[52] Ventura-Clapier R, Garnier A, Veksler V, Joubert F. Bioenergetics of the failing heart. Biochim Biophys Acta 2011; 1813: 1360−1372. doi: 10.1016/j.bbamcr.2010.09.006 [53] Azizi-Namini P, Ahmed M, Yan AT, Keith M. The role of B vitamins in the management of heart failure. Nutr Clin Pract 2012; 27: 363−374. doi: 10.1177/0884533612444539 [54] Lee KS, Moser DK, Park JH, Lennie TA. The association of deficiencies of water-soluble vitamin intake with health-related quality of life and prognosis in patients with heart failure. Qual Life Res 2021; 30: 1183−1190. doi: 10.1007/s11136-020-02725-w [55] Lonn E, Yusuf S, Arnold MJ, et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006; 354: 1567−1577. doi: 10.1056/NEJMoa060900 [56] Herrmann M, Stanger O, Paulweber B, et al. Effect of folate supplementation on N-terminal pro-brain natriuretic peptide. Int J Cardiol 2007; 118: 267−269. doi: 10.1016/j.ijcard.2006.07.034 [57] Bouillon R, Marcocci C, Carmeliet G, et al. Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions. Endocr Rev 2019; 40: 1109−1151. doi: 10.1210/er.2018-00126 [58] Pilz S, März W, Wellnitz B, et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab 2008; 93: 3927−3935. doi: 10.1210/jc.2008-0784 [59] Boxer RS, Dauser DA, Walsh SJ, et al. The association between vitamin D and inflammation with the 6-minute walk and frailty in patients with heart failure. J Am Geriatr Soc 2008; 56: 454−461. doi: 10.1111/j.1532-5415.2007.01601.x [60] Virtanen JK, Nurmi T, Aro A, et al. Vitamin D supplementation and prevention of cardiovascular disease and cancer in the Finnish vitamin D trial-a randomized controlled trial. Am J Clin Nutr 2022; 115: 1300−1310. doi: 10.1093/ajcn/nqab419 [61] Dahlen B, Müller F, Tröbs S-O, et al. Sex-specific relationship between parathyroid hormone and platelet indices in phenotypes of heart failure—results from the MyoVasc Study. Front Cardiovasc Med 2021; 8: 682521. doi: 10.3389/fcvm.2021.682521 [62] Wannamethee SG, Welsh P, Papacosta O, et al. Elevated parathyroid hormone, but not vitamin D deficiency, is associated with increased risk of heart failure in older men with and without cardiovascular disease. Circ Heart Fail 2014; 7: 732−739. doi: 10.1161/CIRCHEARTFAILURE.114.001272